eQHealth Solutions names new senior medical director

A new medical executive has joined eQHealth Solutions, a population health management company that serves government and commercial organizations.

Ellyn Theophilopoulos, MD, JD, began duties this week as corporate senior medical director, the company said in a statement. She’s a graduate of the University of Florida’s College of Medicine and the Stetson University College of Law and is board certified in pediatrics.

In her new role, she will provide clinical oversight of client contracts and serve as the medical and clinical lead that engages with clients on a regular basis.

Prior to joining eQHealth, she was a medical legal consultant for the U.S. Attorney’s Office, a hospitalist at East Lake Pediatrics and an assistant professor of pediatrics at the University of South Florida.

“I am pleased Dr. Theophilopoulos will be joining our organization,” said Glen J. Golemi, president and CEO of eQHealth, in a statement. “Her unique background coupled with her insights, strategic direction and guidance will prove invaluable in leading clinical operations and physician review processes across our client base.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.